Readystate Asset Management’s AbbVie ABBV Stock Holding History

Readystate Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,747	Closed	-$2.09M	–	592
2024 Q4	$1.91M	Buy	+10,747	New	+$1.98M	0.06%	325

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Readystate Asset Management's ABBV Position: Q1 2025 in Review

Readystate Asset Management sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 10,747 shares — an estimated $2.09M sold.

Readystate Asset Management first reported a position in ABBV in Q4 2024 and held it in 1 quarter. The position peaked at $1.91M in Q4 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Readystate Asset Management reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
Readystate Asset Management sold 10,747 AbbVie shares in Q1 2025, an estimated $2.09M.
Readystate Asset Management first reported a position in AbbVie in Q4 2024 and held it in 1 quarter.
Readystate Asset Management's AbbVie position peaked at $1.91M in Q4 2024.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Readystate Asset Management's 13F filing for Q1 2025, filed 6 May 2025.